CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Lukatch Heath Director | Grant or award | +2,265 | 19,481 | ||
| 2026-06-15 | Lukatch Heath Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2025-06-12 | Lukatch Heath Director | Grant or award | +3,041 | 17,216 | ||
| 2025-06-12 | Lukatch Heath Director | Grant or award · Stock Option (right to buy) | +15,372 | 15,372 | ||
| 2025-04-08 | Lukatch Heath Director | Option exercise | +6,000 | $16.00 | $96K | 13,175 |
| 2025-04-08 | Lukatch Heath Director | Option exercise | +1,000 | $21.49 | $21K | 14,175 |
| 2025-04-08 | Lukatch Heath Director | Option exercise · Stock Option (right to buy) | −6,000 | 0 | ||
| 2025-04-08 | Lukatch Heath Director | Option exercise · Stock Option (right to buy) | −1,000 | 14,000 | ||
| 2024-06-06 | Lukatch Heath Director | Grant or award | +1,550 | 7,175 | ||
| 2024-06-06 | Lukatch Heath Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-01-31 | Lukatch Heath Director | Option exercise 10b5-1 | +5,000 | $16.00 | $80K | 10,625 |
| 2024-01-31 | Lukatch Heath Director | Sale 10b5-1 | −5,000 | $71.50 | $358K | 5,625 |
| 2024-01-31 | Lukatch Heath Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 6,000 | ||
| 2024-01-29 | Lukatch Heath Director | Option exercise 10b5-1 | +4,000 | $16.00 | $64K | 9,625 |
| 2024-01-29 | Lukatch Heath Director | Sale 10b5-1 | −4,000 | $67.50 | $270K | 5,625 |
| 2024-01-29 | Lukatch Heath Director | Option exercise · Stock Option (right to buy) 10b5-1 | −4,000 | 11,000 | ||
| 2024-01-02 | Lukatch Heath Director | Option exercise 10b5-1 | +13,000 | $16.00 | $208K | 18,625 |
| 2024-01-02 | Lukatch Heath Director | Sale 10b5-1 | −1,101 | $62.85 | $69K | 17,524 |
| 2024-01-02 | Lukatch Heath Director | Sale 10b5-1 | −7,444 | $63.55 | $473K | 10,080 |
| 2024-01-02 | Lukatch Heath Director | Sale 10b5-1 | −4,164 | $64.28 | $268K | 5,916 |
Page 1 of 3 · 44 trades